Argent Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Argent Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$857K	Sell	1,710 -31,892	-95%	-$15.3M	0.03%	126
2026 Q1	$16.5M	Sell	33,602 -18,757	-36%	-$10.2M	0.52%	49
2025 Q4	$30.3M	Buy	52,359 +16,439	+46%	+$9.3M	0.86%	33
2025 Q3	$17.4M	Sell	35,920 -364	-1%	-$169K	0.48%	48
2025 Q2	$14.7M	Buy	36,284 +958	+3%	+$401K	0.42%	54
2025 Q1	$17.6M	Sell	35,326 -1,336	-4%	-$724K	0.54%	52
2024 Q4	$19.1M	Sell	36,662 -2,049	-5%	-$1.13M	0.54%	47
2024 Q3	$23.9M	Sell	38,711 -1,114	-3%	-$659K	0.66%	47
2024 Q2	$22M	Sell	39,825 -453	-1%	-$260K	0.65%	47
2024 Q1	$23.4M	Sell	40,278 -2,692	-6%	-$1.51M	0.68%	45
2023 Q4	$22.8M	Sell	42,970 -2,499	-5%	-$1.21M	0.74%	38
2023 Q3	$23M	Buy	45,469 +42,217	+1,298%	+$22.5M	0.82%	39
2023 Q2	$1.7M	Hold	3,252	–	–	0.06%	90
2023 Q1	$1.87M	Buy	3,252 +210	+7%	+$118K	0.06%	89
2022 Q4	$1.68M	Hold	3,042	–	–	0.06%	91
2022 Q3	$1.54M	Hold	3,042	–	–	0.06%	95
2022 Q2	$1.65M	Hold	3,042	–	–	0.06%	93
2022 Q1	$1.8M	Hold	3,042	–	–	0.06%	95
2021 Q4	$2.03M	Hold	3,042	–	–	0.06%	94
2021 Q3	$1.74M	Hold	3,042	–	–	0.06%	97
2021 Q2	$1.53M	Hold	3,042	–	–	0.05%	104
2021 Q1	$1.39M	Hold	3,042	–	–	0.05%	103
2020 Q4	$1.42M	Sell	3,042 -190	-6%	-$89.1K	0.05%	105
2020 Q3	$1.43M	Hold	3,232	–	–	0.05%	107
2020 Q2	$1.17M	Hold	3,232	–	–	0.05%	120
2020 Q1	$917K	Buy	+3,232	New	+$1.02M	0.04%	134

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Argent Capital Management's TMO Position: Q2 2026 in Review

Argent Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 95% in Q2 2026, selling an estimated $15.3M and leaving 1,710 shares worth $857K. The position accounts for 0.03% of the portfolio, ranked #126.

Argent Capital Management first reported a position in TMO in Q1 2020 and has held it in 26 quarters since. The position peaked at $30.3M in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Argent Capital Management held 1,710 shares of Thermo Fisher Scientific worth $857K as of Q2 2026.
Argent Capital Management sold 31,892 Thermo Fisher Scientific shares in Q2 2026, an estimated $15.3M.
Thermo Fisher Scientific made up 0.03% of Argent Capital Management's portfolio in Q2 2026, its #126 holding.
Argent Capital Management first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 26 quarters since.
Argent Capital Management's Thermo Fisher Scientific position peaked at $30.3M in Q4 2025.
2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Argent Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.